| 89M | Name: | Nalpha-[trans-4-(aminomethyl)cyclohexane-1-carbonyl]-N-octyl-O-[(quinolin-2-yl)methyl]-L-tyrosinamide | Formula: | C35 H48 N4 O3 | SMILES: | CCCCCCCCNC(=O)C(NC(=O)C1CCC(CC1)CN)Cc2ccc(cc2)OCc4nc3ccccc3cc4 | InChi: | InChI=1S/C35H48N4O3/c1-2-3-4-5-6-9-22-37-35(41)33(39-34(40)29-16-12-27(24-36)13-17-29)23-26-14-20-31(21-15-26)42-25-30-19-18-28-10-7-8-11-32(28)38-30/h7-8,10-11,14-15,18-21,27,29,33H,2-6,9,12-13,16-17,22-25,36H2,1H3,(H,37,41)(H,39,40)/t27-,29-,33-/m0/s1 | Definition date: | 2017-01-12 | Last modified: | 2017-05-26 | Release date: | 2017-05-31 | Identifier: | Nalpha-[trans-4-(aminomethyl)cyclohexane-1-carbonyl]-N-octyl-O-[(quinolin-2-yl)methyl]-L-tyrosinamide |
|
| 89S | Name: | Nalpha-[trans-4-(aminomethyl)cyclohexane-1-carbonyl]-N-octyl-O-[(pyridin-4-yl)methyl]-L-tyrosinamide | Formula: | C31 H46 N4 O3 | SMILES: | CCCCCCCCNC(=O)C(NC(=O)C1CCC(CN)CC1)Cc2ccc(cc2)OCc3ccncc3 | InChi: | InChI=1S/C31H46N4O3/c1-2-3-4-5-6-7-18-34-31(37)29(35-30(36)27-12-8-25(22-32)9-13-27)21-24-10-14-28(15-11-24)38-23-26-16-19-33-20-17-26/h10-11,14-17,19-20,25,27,29H,2-9,12-13,18,21-23,32H2,1H3,(H,34,37)(H,35,36)/t25-,27-,29-/m0/s1 | Definition date: | 2017-01-12 | Last modified: | 2017-05-26 | Release date: | 2017-05-31 | Identifier: | Nalpha-[trans-4-(aminomethyl)cyclohexane-1-carbonyl]-N-octyl-O-[(pyridin-4-yl)methyl]-L-tyrosinamide |
|
| 8EW | Name: | 3-methylpent-2-enedioic acid | Formula: | C6 H8 O4 | SMILES: | CC(CC(O)=O)=CC(O)=O | InChi: | InChI=1S/C6H8O4/c1-4(2-5(7)8)3-6(9)10/h2H,3H2,1H3,(H,7,8)(H,9,10) | Definition date: | 2017-02-02 | Last modified: | 2017-05-26 | Release date: | 2017-05-31 | Identifier: | 3-methylpent-2-enedioic acid |
|
| 8EZ | Name: | (1~{R},2~{S})-2-methylcyclohexane-1-carboxylic acid | Formula: | C8 H14 O2 | SMILES: | C[CH]1CCCC[CH]1C(O)=O | InChi: | InChI=1S/C8H14O2/c1-6-4-2-3-5-7(6)8(9)10/h6-7H,2-5H2,1H3,(H,9,10)/t6-,7+/m0/s1 | Definition date: | 2017-02-02 | Last modified: | 2017-05-26 | Release date: | 2017-05-31 | Identifier: | (1~{R},2~{S})-2-methylcyclohexane-1-carboxylic acid |
|
| 8FK | Name: | (2~{S})-~{N}-(5-methyl-6-oxidanylidene-benzo[b][1,4]benzothiazepin-2-yl)oxolane-2-carboxamide | Formula: | C19 H18 N2 O3 S | SMILES: | CN1C(=O)c2ccccc2Sc3cc(NC(=O)[CH]4CCCO4)ccc13 | InChi: | InChI=1S/C19H18N2O3S/c1-21-14-9-8-12(20-18(22)15-6-4-10-24-15)11-17(14)25-16-7-3-2-5-13(16)19(21)23/h2-3,5,7-9,11,15H,4,6,10H2,1H3,(H,20,22)/t15-/m0/s1 | Definition date: | 2017-02-06 | Last modified: | 2017-05-26 | Release date: | 2017-05-31 | Identifier: | (2~{S})-~{N}-(5-methyl-6-oxidanylidene-benzo[b][1,4]benzothiazepin-2-yl)oxolane-2-carboxamide |
|
| 8FN | Name: | 5-cyclopropyl-2-(5-pyrazin-2-yl-1,2,4-oxadiazol-3-yl)benzo[b][1,4]benzothiazepin-6-one | Formula: | C22 H15 N5 O2 S | SMILES: | O=C1N(C2CC2)c3ccc(cc3Sc4ccccc14)c5noc(n5)c6cnccn6 | InChi: | InChI=1S/C22H15N5O2S/c28-22-15-3-1-2-4-18(15)30-19-11-13(5-8-17(19)27(22)14-6-7-14)20-25-21(29-26-20)16-12-23-9-10-24-16/h1-5,8-12,14H,6-7H2 | Definition date: | 2017-02-06 | Last modified: | 2017-05-26 | Release date: | 2017-05-31 | Identifier: | 5-cyclopropyl-2-(5-pyrazin-2-yl-1,2,4-oxadiazol-3-yl)benzo[b][1,4]benzothiazepin-6-one |
|
| 8HZ | Name: | 4-[8-methyl-3-[(4-methylphenyl)amino]imidazo[1,2-a]pyridin-2-yl]phenol | Formula: | C21 H19 N3 O | SMILES: | Cc1ccc(Nc2n3cccc(C)c3nc2c4ccc(O)cc4)cc1 | InChi: | InChI=1S/C21H19N3O/c1-14-5-9-17(10-6-14)22-21-19(16-7-11-18(25)12-8-16)23-20-15(2)4-3-13-24(20)21/h3-13,22,25H,1-2H3 | Definition date: | 2017-02-08 | Last modified: | 2017-05-26 | Release date: | 2017-05-31 | Identifier: | 4-[8-methyl-3-[(4-methylphenyl)amino]imidazo[1,2-a]pyridin-2-yl]phenol |
|
| 8LD | Name: | 2,2'-oxydi(ethyn-1-ol) | Formula: | C4 H2 O3 | SMILES: | OC#COC#CO | InChi: | InChI=1S/C4H2O3/c5-1-3-7-4-2-6/h5-6H | Definition date: | 2017-02-13 | Last modified: | 2017-05-26 | Release date: | 2017-05-31 | Identifier: | 2,2'-oxydi(ethyn-1-ol) |
|
| 8PT | Name: | ~{N}6-cyclohexyl-~{N}2-(2-methyl-4-morpholin-4-yl-phenyl)-7~{H}-purine-2,6-diamine | Formula: | C22 H29 N7 O | SMILES: | Cc1cc(ccc1Nc2nc(NC3CCCCC3)c4[nH]cnc4n2)N5CCOCC5 | InChi: | InChI=1S/C22H29N7O/c1-15-13-17(29-9-11-30-12-10-29)7-8-18(15)26-22-27-20-19(23-14-24-20)21(28-22)25-16-5-3-2-4-6-16/h7-8,13-14,16H,2-6,9-12H2,1H3,(H3,23,24,25,26,27,28) | Definition date: | 2017-02-21 | Last modified: | 2017-05-26 | Release date: | 2017-05-31 | Identifier: | ~{N}6-cyclohexyl-~{N}2-(2-methyl-4-morpholin-4-yl-phenyl)-7~{H}-purine-2,6-diamine |
|
| 8Q5 | Name: | ~{N}-cyclopropyl-4-[8-(2-methylpropylamino)imidazo[1,2-a]pyrazin-3-yl]benzamide | Formula: | C20 H23 N5 O | SMILES: | CC(C)CNc1nccn2c(cnc12)c3ccc(cc3)C(=O)NC4CC4 | InChi: | InChI=1S/C20H23N5O/c1-13(2)11-22-18-19-23-12-17(25(19)10-9-21-18)14-3-5-15(6-4-14)20(26)24-16-7-8-16/h3-6,9-10,12-13,16H,7-8,11H2,1-2H3,(H,21,22)(H,24,26) | Definition date: | 2017-02-23 | Last modified: | 2017-05-26 | Release date: | 2017-05-31 | Identifier: | ~{N}-cyclopropyl-4-[8-(2-methylpropylamino)imidazo[1,2-a]pyrazin-3-yl]benzamide |
|
| 8QE | Name: | 4-[[4-azanyl-6-(~{tert}-butylamino)-5-cyano-pyridin-2-yl]amino]benzamide | Formula: | C17 H20 N6 O | SMILES: | CC(C)(C)Nc1nc(Nc2ccc(cc2)C(N)=O)cc(N)c1C#N | InChi: | InChI=1S/C17H20N6O/c1-17(2,3)23-16-12(9-18)13(19)8-14(22-16)21-11-6-4-10(5-7-11)15(20)24/h4-8H,1-3H3,(H2,20,24)(H4,19,21,22,23) | Definition date: | 2017-02-24 | Last modified: | 2017-05-26 | Release date: | 2017-05-31 | Identifier: | 4-[[4-azanyl-6-(~{tert}-butylamino)-5-cyano-pyridin-2-yl]amino]benzamide |
|
| 8QW | Name: | (2~{R})-2-(4-fluorophenyl)-~{N}-[4-[2-[(2-methoxy-4-methylsulfonyl-phenyl)amino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]propanamide | Formula: | C29 H26 F N5 O4 S | SMILES: | COc1cc(ccc1Nc2nn3cc(ccc3n2)c4ccc(NC(=O)[CH](C)c5ccc(F)cc5)cc4)[S](C)(=O)=O | InChi: | InChI=1S/C29H26FN5O4S/c1-18(19-4-9-22(30)10-5-19)28(36)31-23-11-6-20(7-12-23)21-8-15-27-33-29(34-35(27)17-21)32-25-14-13-24(40(3,37)38)16-26(25)39-2/h4-18H,1-3H3,(H,31,36)(H,32,34)/t18-/m1/s1 | Definition date: | 2017-02-27 | Last modified: | 2017-05-26 | Release date: | 2017-05-31 | Identifier: | (2~{R})-2-(4-fluorophenyl)-~{N}-[4-[2-[(2-methoxy-4-methylsulfonyl-phenyl)amino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]propanamide |
|
| 8QZ | Name: | ~{N}-[3,5-diethyl-1-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]pyrazol-4-yl]-2-[[2-methoxy-4-[4-(2-methoxyethanoyl)piperazin-1-yl]phenyl]amino]-5,6-dihydropyrimido[4,5-e]indolizine-7-carboxamide | Formula: | C39 H53 N9 O7 | SMILES: | CCc1nn(CCOCCOCCOC)c(CC)c1NC(=O)c2ccn3c2CCc4cnc(Nc5ccc(cc5OC)N6CCN(CC6)C(=O)COC)nc34 | InChi: | InChI=1S/C39H53N9O7/c1-6-30-36(32(7-2)48(44-30)18-19-54-22-23-55-21-20-51-3)42-38(50)29-12-13-47-33(29)11-8-27-25-40-39(43-37(27)47)41-31-10-9-28(24-34(31)53-5)45-14-16-46(17-15-45)35(49)26-52-4/h9-10,12-13,24-25H,6-8,11,14-23,26H2,1-5H3,(H,42,50)(H,40,41,43) | Definition date: | 2017-02-27 | Last modified: | 2017-05-26 | Release date: | 2017-05-31 | Identifier: | ~{N}-[3,5-diethyl-1-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]pyrazol-4-yl]-2-[[2-methoxy-4-[4-(2-methoxyethanoyl)piperazin-1-yl]phenyl]amino]-5,6-dihydropyrimido[4,5-e]indolizine-7-carboxamide |
|
| 8RH | Name: | BAY 1217389 | Formula: | C27 H24 F5 N5 O3 | SMILES: | COc1ccc(Oc2cc(NCCC(F)(F)F)c3ncc(n3n2)c4ccc(c(C)c4)C(=O)NC5CC5)c(F)c1F | InChi: | InChI=1S/C27H24F5N5O3/c1-14-11-15(3-6-17(14)26(38)35-16-4-5-16)19-13-34-25-18(33-10-9-27(30,31)32)12-22(36-37(19)25)40-21-8-7-20(39-2)23(28)24(21)29/h3,6-8,11-13,16,33H,4-5,9-10H2,1-2H3,(H,35,38) | Definition date: | 2017-02-28 | Last modified: | 2017-05-26 | Release date: | 2017-05-31 | Identifier: | 4-[6-[2,3-bis(fluoranyl)-4-methoxy-phenoxy]-8-[3,3,3-tris(fluoranyl)propylamino]imidazo[1,2-b]pyridazin-3-yl]-~{N}-cyclopropyl-2-methyl-benzamide |
|
| 8WJ | Name: | (2S)-3-cyclohexyl-2-[4-(cyclopentylsulfonyl)-2-oxopyridin-1(2H)-yl]-N-(1,3-thiazol-2-yl)propanamide | Formula: | C22 H29 N3 O4 S2 | SMILES: | N(c1sccn1)C(=O)C(CC2CCCCC2)N3C(C=C(C=C3)S(C4CCCC4)(=O)=O)=O | InChi: | InChI=1S/C22H29N3O4S2/c26-20-15-18(31(28,29)17-8-4-5-9-17)10-12-25(20)19(14-16-6-2-1-3-7-16)21(27)24-22-23-11-13-30-22/h10-13,15-17,19H,1-9,14H2,(H,23,24,27)/t19-/m0/s1 | Definition date: | 2017-03-13 | Last modified: | 2017-05-26 | Release date: | 2017-05-31 | Identifier: | (2S)-3-cyclohexyl-2-[4-(cyclopentylsulfonyl)-2-oxopyridin-1(2H)-yl]-N-(1,3-thiazol-2-yl)propanamide |
|
| 8WM | Name: | (2S)-2-[4-(cyclopropylsulfonyl)-1H-indazol-1-yl]-N-(5-fluoro-1,3-thiazol-2-yl)-3-(oxan-4-yl)propanamide | Formula: | C21 H23 F N4 O4 S2 | SMILES: | c1(sc(F)cn1)NC(=O)C(CC2CCOCC2)n3c4c(cn3)c(ccc4)S(=O)(=O)C5CC5 | InChi: | InChI=1S/C21H23FN4O4S2/c22-19-12-23-21(31-19)25-20(27)17(10-13-6-8-30-9-7-13)26-16-2-1-3-18(15(16)11-24-26)32(28,29)14-4-5-14/h1-3,11-14,17H,4-10H2,(H,23,25,27)/t17-/m0/s1 | Definition date: | 2017-03-13 | Last modified: | 2017-05-26 | Release date: | 2017-05-31 | Identifier: | (2S)-2-[4-(cyclopropylsulfonyl)-1H-indazol-1-yl]-N-(5-fluoro-1,3-thiazol-2-yl)-3-(oxan-4-yl)propanamide |
|
| 8Z2 | Name: | ~{S}-[2-[3-[[(2~{R})-4-[[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-4-oxidanyl-3-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxy-3,3-dimethyl-2-oxidanyl-butanoyl]amino]propanoylamino]ethyl] (~{E})-dodec-2-enethioate | Formula: | C33 H56 N7 O17 P3 S | SMILES: | CCCCCCCCCC=CC(=O)SCCNC(=O)CCNC(=O)[CH](O)C(C)(C)CO[P](O)(=O)O[P](O)(=O)OC[CH]1O[CH]([CH](O)[CH]1O[P](O)(O)=O)n2cnc3c(N)ncnc23 | InChi: | InChI=1S/C33H56N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-24(42)61-17-16-35-23(41)14-15-36-31(45)28(44)33(2,3)19-54-60(51,52)57-59(49,50)53-18-22-27(56-58(46,47)48)26(43)32(55-22)40-21-39-25-29(34)37-20-38-30(25)40/h12-13,20-22,26-28,32,43-44H,4-11,14-19H2,1-3H3,(H,35,41)(H,36,45)(H,49,50)(H,51,52)(H2,34,37,38)(H2,46,47,48)/b13-12+/t22-,26-,27-,28+,32-/m1/s1 | Definition date: | 2017-03-28 | Last modified: | 2017-05-26 | Release date: | 2017-05-31 | Identifier: | ~{S}-[2-[3-[[(2~{R})-4-[[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-4-oxidanyl-3-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxy-3,3-dimethyl-2-oxidanyl-butanoyl]amino]propanoylamino]ethyl] (~{E})-dodec-2-enethioate |
|
| 91Y | Name: | 3-[(cyclohexanecarbonyl)amino]-N-(2,3-dihydro-1H-inden-2-yl)pyrazine-2-carboxamide | Formula: | C21 H24 N4 O2 | SMILES: | N(c3c(C(=O)NC2Cc1c(cccc1)C2)nccn3)C(C4CCCCC4)=O | InChi: | InChI=1S/C21H24N4O2/c26-20(14-6-2-1-3-7-14)25-19-18(22-10-11-23-19)21(27)24-17-12-15-8-4-5-9-16(15)13-17/h4-5,8-11,14,17H,1-3,6-7,12-13H2,(H,24,27)(H,23,25,26) | Definition date: | 2017-03-28 | Last modified: | 2017-05-26 | Release date: | 2017-05-31 | Identifier: | 3-[(cyclohexanecarbonyl)amino]-N-(2,3-dihydro-1H-inden-2-yl)pyrazine-2-carboxamide |
|
| 9H8 | Name: | 1,1,1-tris(fluoranyl)-~{N}-[[(2~{S})-pyrrolidin-2-yl]methyl]methanesulfonamide | Formula: | C6 H11 F3 N2 O2 S | SMILES: | FC(F)(F)[S](=O)(=O)NC[CH]1CCCN1 | InChi: | InChI=1S/C6H11F3N2O2S/c7-6(8,9)14(12,13)11-4-5-2-1-3-10-5/h5,10-11H,1-4H2/t5-/m0/s1 | Definition date: | 2017-05-18 | Last modified: | 2017-05-26 | Release date: | 2017-05-31 | Identifier: | 1,1,1-tris(fluoranyl)-~{N}-[[(2~{S})-pyrrolidin-2-yl]methyl]methanesulfonamide |
|
| 9HV | Name: | {2-[(2R,3R,4R,5R)-3-(alpha-D-glucopyranosyloxy)-4-hydroxy-2,5-bis(hydroxymethyl)pyrrolidin-1-yl]ethyl}phosphonic acid | Formula: | C14 H28 N O12 P | SMILES: | C1(N(CCP(O)(O)=O)C(CO)C(C1O)OC2C(O)C(C(C(CO)O2)O)O)CO | InChi: | InChI=1S/C14H28NO12P/c16-3-6-9(19)13(7(4-17)15(6)1-2-28(23,24)25)27-14-12(22)11(21)10(20)8(5-18)26-14/h6-14,16-22H,1-5H2,(H2,23,24,25)/t6-,7-,8-,9-,10-,11+,12-,13-,14-/m1/s1 | Definition date: | 2017-05-12 | Last modified: | 2017-05-26 | Release date: | 2017-05-31 | Identifier: | {2-[(2R,3R,4R,5R)-3-(alpha-D-glucopyranosyloxy)-4-hydroxy-2,5-bis(hydroxymethyl)pyrrolidin-1-yl]ethyl}phosphonic acid |
|
| 9J4 | Name: | 4-{[(1R,3S)-3-amino-2,2,3-trimethylcyclopentyl]amino}-6-phenylpyrrolo[1,2-b]pyridazine-3-carboxamide | Formula: | C22 H27 N5 O | SMILES: | C1CC(C(C1(N)C)(C)C)Nc2c3n(ncc2C(N)=O)cc(c3)c4ccccc4 | InChi: | InChI=1S/C22H27N5O/c1-21(2)18(9-10-22(21,3)24)26-19-16(20(23)28)12-25-27-13-15(11-17(19)27)14-7-5-4-6-8-14/h4-8,11-13,18,26H,9-10,24H2,1-3H3,(H2,23,28)/t18-,22+/m1/s1 | Definition date: | 2017-05-12 | Last modified: | 2017-05-26 | Release date: | 2017-05-31 | Identifier: | 4-{[(1R,3S)-3-amino-2,2,3-trimethylcyclopentyl]amino}-6-phenylpyrrolo[1,2-b]pyridazine-3-carboxamide |
|
| YRA | Name: | 3-[(3-chloranyl-4-phenyl-phenyl)methylamino]propanamide | Formula: | C16 H17 Cl N2 O | SMILES: | NC(=O)CCNCc1ccc(c(Cl)c1)c2ccccc2 | InChi: | InChI=1S/C16H17ClN2O/c17-15-10-12(11-19-9-8-16(18)20)6-7-14(15)13-4-2-1-3-5-13/h1-7,10,19H,8-9,11H2,(H2,18,20) | Definition date: | 2016-12-14 | Last modified: | 2017-05-19 | Release date: | 2017-05-24 | Identifier: | 3-[(3-chloranyl-4-phenyl-phenyl)methylamino]propanamide |
|
| J2P | Name: | (3-chloranyl-4-phenyl-phenyl)methyl-ethyl-azanium | Formula: | C15 H17 Cl N | SMILES: | CC[NH2+]Cc1ccc(c(Cl)c1)c2ccccc2 | InChi: | InChI=1S/C15H16ClN/c1-2-17-11-12-8-9-14(15(16)10-12)13-6-4-3-5-7-13/h3-10,17H,2,11H2,1H3/p+1 | Definition date: | 2016-12-16 | Last modified: | 2017-05-19 | Release date: | 2017-05-24 | Identifier: | (3-chloranyl-4-phenyl-phenyl)methyl-ethyl-azanium |
|
| YTX | Name: | 2-(3-methoxy-4-oxidanyl-phenyl)ethanoic acid | Formula: | C9 H10 O4 | SMILES: | COc1cc(CC(O)=O)ccc1O | InChi: | InChI=1S/C9H10O4/c1-13-8-4-6(5-9(11)12)2-3-7(8)10/h2-4,10H,5H2,1H3,(H,11,12) | Definition date: | 2016-12-14 | Last modified: | 2017-05-19 | Release date: | 2017-05-24 | Identifier: | 2-(3-methoxy-4-oxidanyl-phenyl)ethanoic acid |
|
| WOT | Name: | phenylazanium | Formula: | C6 H8 N | SMILES: | [NH3+]c1ccccc1 | InChi: | InChI=1S/C6H7N/c7-6-4-2-1-3-5-6/h1-5H,7H2/p+1 | Definition date: | 2016-12-22 | Last modified: | 2017-05-19 | Release date: | 2017-05-24 | Identifier: | phenylazanium |
|